• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,543.77 1,015.82
( 1.34%)
Global Indices
Nasdaq
51,233.54 363.79
(0.72%)
Dow Jones
7,453.14 37.84
(0.51%)
Hang Seng
66,063.56 1,846.29
(2.88%)
Nikkei 225
10,460.24 156.36
(1.52%)
Forex
USD-INR
95.49 0.16
(0.17%)
EUR-INR
110.25 0.17
(0.15%)
GBP-INR
127.74 0.15
(0.12%)
JPY-INR
0.60 0.00
(0.21%)

EQUITY - MARKET SCREENER

Wockhardt Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532300
INE049B01025
189.8089072
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
WOCKPHARMA
107.68
31441.42
EPS(TTM)
Face Value()
Div & Yield %
17.97
5
0
 

TGV Sraac standalone net profit rises 28.99% in the March 2026 quarter
May 22,2026
Net profit of TGV Sraac rose 28.99% to Rs 27.99 crore in the quarter ended March 2026 as against Rs 21.70 crore during the previous quarter ended March 2025. Sales rose 4.99% to Rs 511.11 crore in the quarter ended March 2026 as against Rs 486.83 crore during the previous quarter ended March 2025.

For the full year,net profit rose 43.17% to Rs 131.89 crore in the year ended March 2026 as against Rs 92.12 crore during the previous year ended March 2025. Sales rose 11.50% to Rs 1950.24 crore in the year ended March 2026 as against Rs 1749.04 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales511.11486.83 5 1950.241749.04 12
OPM %16.5612.04 -17.9312.86 -
PBDT80.3355.03 46 342.58213.63 60
PBT38.2030.21 26 178.48125.55 42
NP27.9921.70 29 131.8992.12 43